Karyopharm to Participate at 11th Annual SVB Leerink Global Healthcare Conference

NEWTON, Mass., Feb. 11, 2022 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that Richard Paulson, President and Chief Executive Officer of Karyopharm, will participate in a fireside…

About the Author

has written 41821 stories on this site.

Copyright © 2010 Business and Corporate News.